Literature DB >> 34363508

Imminent cognitive decline in normal elderly individuals is associated with hippocampal hyperconnectivity in the variant neural correlates of episodic memory.

Hao Shu1,2, Gang Chen2, B Douglas Ward2, Guangyu Chen2, Zan Wang1, Duan Liu1, Fan Su1, Lihua Gu1, Zhan Xu2, Shi-Jiang Li3, Zhijun Zhang4.   

Abstract

The secondary prevention trials of Alzheimer's disease (AD) require an enrichment strategy to recruit individuals with imminent cognitive decline at the preclinical stage. Previously, we demonstrated a variant neural correlates of episodic memory (EM) function in apolipoprotein E (APOE) ε4 carriers. Herein, we investigated whether this variation was associated with longitudinal EM performance. This 3-year longitudinal study included 88 normal elderly subjects with EM assessment and resting-state functional MRI data at baseline; 48 subjects (27 ε3 homozygotes and 21 ε4 carriers) underwent follow-up EM assessment. In the identified EM neural correlates, multivariable regression models examined the association between hippocampal functional connectivity (HFC) and longitudinal EM change. Independent validation was performed using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. At baseline, the EM neural correlates were characterized in the Papez circuit regions in the ε3 homozygotes, but in the sensorimotor cortex and cuneus in the ε4 carriers. Longitudinally, the ε4 carriers exhibited a negative association of the baseline HFC strength in the EM neural correlates with annual rate of EM change (R2 = 0.25, p = 0.05). This association also showed a trend in the ADNI dataset (R2 = 0.42, p = 0.06). These results indicate that hippocampal hyperconnectivity in the variant EM neural correlates is associated with imminent EM decline in ε4 carriers, which may serve as a promising enrichment strategy for secondary prevention trials of AD.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Apolipoprotein E; Degeneracy; Episodic memory; Functional connectivity; Hippocampus

Mesh:

Substances:

Year:  2021        PMID: 34363508     DOI: 10.1007/s00406-021-01310-7

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.760


  46 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.

Authors:  Marc Aurel Busche; Xiaowei Chen; Horst A Henning; Julia Reichwald; Matthias Staufenbiel; Bert Sakmann; Arthur Konnerth
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-16       Impact factor: 11.205

3.  Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele.

Authors:  Nicola Filippini; Bradley J MacIntosh; Morgan G Hough; Guy M Goodwin; Giovanni B Frisoni; Stephen M Smith; Paul M Matthews; Christian F Beckmann; Clare E Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-08       Impact factor: 11.205

4.  Where is hippocampal activity in the cascade of Alzheimer's disease biomarkers?

Authors:  Howard J Aizenstein; William E Klunk
Journal:  Brain       Date:  2015-04       Impact factor: 13.501

5.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Ronald C Petersen; Michael W Weiner; Paul S Aisen; Leslie M Shaw; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Vernon S Pankratz; Michael C Donohue; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

6.  Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.

Authors:  Anja Soldan; Corinne Pettigrew; Qing Cai; Mei-Cheng Wang; Abhay R Moghekar; Richard J O'Brien; Ola A Selnes; Marilyn S Albert
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

7.  Amyloid deposition is associated with impaired default network function in older persons without dementia.

Authors:  Reisa A Sperling; Peter S Laviolette; Kelly O'Keefe; Jacqueline O'Brien; Dorene M Rentz; Maija Pihlajamaki; Gad Marshall; Bradley T Hyman; Dennis J Selkoe; Trey Hedden; Randy L Buckner; J Alex Becker; Keith A Johnson
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

8.  Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later.

Authors:  Catherine M Roe; Anne M Fagan; Elizabeth A Grant; Jason Hassenstab; Krista L Moulder; Denise Maue Dreyfus; Courtney L Sutphen; Tammie L S Benzinger; Mark A Mintun; David M Holtzman; John C Morris
Journal:  Neurology       Date:  2013-04-10       Impact factor: 9.910

9.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition.

Authors:  Adam W Bero; Ping Yan; Jee Hoon Roh; John R Cirrito; Floy R Stewart; Marcus E Raichle; Jin-Moo Lee; David M Holtzman
Journal:  Nat Neurosci       Date:  2011-05-01       Impact factor: 24.884

10.  Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers.

Authors:  Guangyu Chen; Hao Shu; Gang Chen; B Douglas Ward; Piero G Antuono; Zhijun Zhang; Shi-Jiang Li
Journal:  J Alzheimers Dis       Date:  2016-10-04       Impact factor: 4.472

View more
  1 in total

1.  Episodic Memory, Hippocampal Volume, and Function for Classification of Mild Cognitive Impairment Patients Regarding Amyloid Pathology.

Authors:  Eliane Correa Miotto; Sonia Maria Dozzi Brucki; Carlos T Cerqueira; Paulo R Bazán; Geise Aline de Almeida Silva; Maria da Graça M Martin; Paula Squarzoni da Silveira; Daniele de Paula Faria; Artur Martins Coutinho; Carlos Alberto Buchpiguel; Geraldo Busatto Filho; Ricardo Nitrini
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.